• Deep Learning Reveals Cardiotoxicity in iPSC-Derived Models

  2026-07-30

  This study introduces a scalable, deep learning-driven platform for detecting drug-induced cardiotoxicity using high-content imaging of human iPSC-derived cardiomyocytes. The findings demonstrate improved early-stage risk assessment in drug discovery, highlighting both methodological advances and implications for high-content phenotypic screening.

• LuQi Formula Attenuates Post-MI Remodeling via SPTLC2-Cerami

  2026-07-30

  This study demonstrates that the LuQi Formula, a traditional herbal mixture, mitigates ventricular remodeling after myocardial infarction by downregulating SPTLC2 and suppressing de novo ceramide synthesis. These findings provide mechanistic clarity on the role of sphingolipid metabolism in cardiac repair, offering targets for future cardiovascular intervention.

• Remdesivir (GS-5734): Advanced Mechanistic Insights for Anti

  2026-07-29

  Explore the unique mechanistic depth of Remdesivir (GS-5734) as a coronavirus and filovirus inhibitor. This article reveals how structural virology advances are reshaping antiviral assay design and highlights APExBIO's contribution to translational research.

• Peptide-Mediated Macrolide Resistance in the Ribosomal Exit

  2026-07-29

  This study uncovers how short, sequence-specific peptides expressed in bacteria can confer resistance to various macrolide antibiotics, including azithromycin, by interacting with the ribosomal exit tunnel. The findings redefine the tunnel as a functional interface mediating specific drug–peptide–ribosome interactions, illuminating new resistance mechanisms and informing the design of future antibacterial strategies.

• Forskolin: Adenylate Cyclase Activator in Advanced Cell Assa

  2026-07-28

  Forskolin's direct activation of adenylate cyclase enables precise cAMP modulation for cell biology, regenerative medicine, and neuroendocrine research. Explore actionable protocols, troubleshooting insights, and cross-domain innovations for maximizing experimental reproducibility with APExBIO Forskolin.

• BOP Reagent in Translational Prodrug Design: From Mechanism

  2026-07-28

  This thought-leadership article explores how BOP reagent (benzotriazol-1-yloxy-tris(dimethylamino)phosphanium hexafluorophosphate) advances the frontier of translational peptide and prodrug research. By bridging molecular mechanism, practical protocol guidance, and the evolving demands of carrier-free chemotherapeutic development, we contextualize BOP’s pivotal role in next-generation peptide workflows—culminating in actionable insights for translational scientists tackling complex diseases like oral squamous cell carcinoma (OSCC).

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Enabling Multiplexed

  2026-07-27

  Discover how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody elevates multiplexed immunohistochemistry and immunocytochemistry with robust signal amplification, high specificity, and superior workflow flexibility. Explore its unique role in next-generation vaccine and combination immunoassay research.

• Advances in Plant Protein Secretion: Protocols and Research

  2026-07-27

  This reference work provides a comprehensive overview and detailed protocols for studying protein secretion pathways in plant cells, highlighting both conventional and unconventional mechanisms. Its systematic approach facilitates reproducibility and comparative analysis, supporting the advancement of plant cell biology and its applications in related fields.

• Non-canonical ORF Translation Drives Medulloblastoma Surviva

  2026-07-26

  This study uncovers the widespread translation and functional significance of non-canonical open reading frames (ORFs) in high-risk childhood medulloblastoma. By combining ribosome profiling and high-resolution CRISPR tiling, the authors identify critical microproteins—particularly ASNSD1-uORF—that are essential for tumor cell survival, highlighting new avenues for therapeutic targeting.

• Single-Molecule FRET Reveals SAM-VI Riboswitch Dynamics

  2026-07-25

  This study utilizes single-molecule FRET with position-selective fluorescent labeling to elucidate the dynamic folding and ligand response of the SAM-VI riboswitch. The findings clarify how magnesium ions and S-adenosylmethionine cooperatively regulate riboswitch conformation and gene expression, informing future RNA structure-function research.

• 3-Bromopyruvate and Cetuximab Synergy Overcomes CRC Drug Res

  2026-07-24

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab can overcome intrinsic and acquired cetuximab resistance in colorectal cancer (CRC) cells by inducing autophagy-dependent ferroptosis and apoptosis. The mechanistic insights into FOXO3a pathway modulation provide new therapeutic strategies for resistant CRC.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike-AXL Binding

  2026-07-24

  A recent study demonstrates that certain naturally occurring angiotensin peptide fragments, including those similar to Angiotensin 1/2 (2-7), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings reveal a novel molecular mechanism by which components of the renin-angiotensin system may influence viral entry, with important implications for research into both cardiovascular regulation and COVID-19 pathogenesis.

• Novel PRRSV-1 Strain GD2022: Isolation, Genomics, and Pathog

  2026-07-23

  This study presents the first isolation and detailed genetic characterization of a novel PRRSV-1 strain (GD2022) from southern China. The findings clarify its independent evolutionary status, highlight unique antigenic region mutations, and establish its pathogenicity in piglets, providing a valuable reference point for PRRSV-1 surveillance and control strategies.

• Cinoxacin in Antibacterial Assay Design: Mechanisms & Innova

  2026-07-23

  Explore Cinoxacin, a potent quinolone antibiotic, as a precision tool for advanced antibacterial assay development. This article provides unique insights into its mechanistic action, assay optimization parameters, and key innovations for urinary tract infection research.

• Cyclophilin A Is Essential for Cyclosporine Immunosuppressio

  2026-07-22

  This study demonstrates that cyclophilin A is the critical intracellular mediator required for cyclosporine-induced immunosuppression. By establishing that cyclophilin A-deficient mice are resistant to cyclosporine, the research clarifies the molecular specificity of calcineurin inhibition and informs experimental design in transplantation immunology research.

16139 records 1/1076 page Next 12345 下5页 Last page